Company: STAA
Filing Date: 2025-10-22
Form Type: DFAN14A
Source: 0001213900-25-101288
Chunk: 3

Company: STAAR SURGICAL CO
Filing Date: 2025-10-22
Form: DFAN14A
Chunk 3
---
5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e) 
 ☐                                                                                   |
| 6 | Citizenship or place of organization                                                
 UNITED STATES                                                                       |

| Number of Shares                                  
 Beneficially Owned by Each Reporting Person With: |                        7 | Sole Voting Power 
 0.00              |
| 8                                                 |      Shared Voting Power 
                     0.00 |                   |
| 9                                                 |   Sole Dispositive Power 
                     0.00 |                   |
| 10                                                | Shared Dispositive Power 
                     0.00 |                   |

| 11 | Aggregate amount beneficially owned by each reporting                                
 person                                                                               
 0.00                                                                                 |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions) 
 ☐                                                                                    |
| 13 | Percent of class represented by amount in Row (11)                                   
 0 %                                                                                  |
| 14 | Type of Reporting Person (See Instructions)                                          
 IN                                                                                   |

SCHEDULE 13D

| Item 1. | Security and Issuer |

| (a) | Title of Class of Securities: |

Common Stock, par value $0.01 per share

| (b) | Name of Issuer: |

STAAR SURGICAL CO

| (c) | Address of Issuer's Principal Executive Offices: |

25510 Commercentre Drive, Lake Forest, CA 92630

| Item 1 Comment: | This Amendment No. 39 to the Schedule 13D ("Amendment No. 39"), amends and supplements the statement on Schedule 13D filed with the U.S. Securities 
 and Exchange Commission (the "SEC") on October 12, 2004, (the "Original Schedule 13D," as amended, the "Schedule                                    
 13D") with respect to shares of common stock, par value $0.01 per share (the "Shares") of STAAR Surgical Company (the                               
 "Issuer"). Capitalized terms used but not otherwise defined in this Amendment No. 39 have the meanings set forth in the Schedule                    
 13D.                                                                                                                                                |

| Item 4. | Purpose of Transaction |

Item 4 is hereby amended and supplemented by the addition
of the following:

On October 21, 2025, the Reporting Persons notified
the Board of their intent to call a special meeting of stockholders for the purpose of removing several of the